To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATXN7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
230 supporting clones for gene ATXN7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA092517   .j-u 1597 to 1761 1 to 165       165/165
(100 %)
1 diff
(99.4 %id)
AA095466   .j-u 1597 to 1889 1 to 286       286/289
(98 %)
10 diff
(96.6 %id)
AA174156   .j-u 4520 to 4717 1 to 198       198/198
(100 %)
0 diff
(100 %id)
AA174157   .j-u 4549 to 4717 1 to 169       169/169
(100 %)
0 diff
(100 %id)
AA352207   .c 1672 to 1793 1 to 122       122/122
(100 %)
0 diff
(100 %id)
BU198029 ectopic and normal uterine endometrium .j-u 4489 to 4717 229 to 1       229/229
(100 %)
0 diff
(100 %id)
AF032103 colon .b 862 to 3348 1 to 2487   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 2487/2487
(100 %)
3 diff
(99.9 %id)
AF032104 placenta .a 1 to 728 1 to 728   tiling clone,   728/728
(100 %)
2 diff
(99.8 %id)
AF032105   .b 1 to 3348 1 to 3348 K264R V862M tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3348/3348
(100 %)
6 diff
(99.9 %id)
AJ000517   .c 1 to 3941 1 to 3942 exact tiling clone,   3942/3969
(99 %)
8 diff
(99.8 %id)
AK125125 tongue, tumor tissue .j-u 1 to 3262 7 to 3269 Y15C tiling clone, available from FLJ,   3269/3269
(100 %)
3 diff
(100.0 %id)
AK304062 trachea .d 78 to 2741 1 to 2664 K119R V717M tiling clone,   2664/2664
(100 %)
3 diff
(99.9 %id)
AK310745 thymus .i 1 to 917 2 to 918 exact tiling clone,   918/918
(100 %)
0 diff
(100 %id)
AW387230 stomach .b 3107 to 3308 222 to 21       202/222
(90 %)
0 diff
(100 %id)
AW753877 colon .j-u 2525 to 2878 356 to 2       355/356
(99 %)
0 diff
(100 %id)
AW968957   .c 631 to 1137 7 to 513       507/517
(98 %)
1 diff
(99.9 %id)
AW975945   .j-u 2569 to 3115 94 to 640       547/640
(85 %)
6 diff
(99.1 %id)
AW997253 breast_normal .c 1940 to 2303 382 to 19     Submitted on the opposite strand 364/382
(95 %)
1 diff
(99.8 %id)
AW997259 breast_normal .c 1940 to 2303 379 to 16     Submitted on the opposite strand 364/379
(96 %)
1 diff
(99.8 %id)
AW997332 breast_normal .c 1940 to 2302 397 to 35     Submitted on the opposite strand 363/397
(91 %)
1 diff
(99.8 %id)
BE815691 breast_normal .c 3428 to 3702 278 to 4       275/278
(98 %)
0 diff
(100 %id)
BE932408 head_neck .l-u 1 to 488 499 to 13 exact tiling clone,   487/499
(97 %)
0 diff
(100 %id)
BF086861 placenta_normal .j-u 2699 to 3090 390 to 1       390/403
(96 %)
12 diff
(97.1 %id)
BF327316 breast_normal .j-u 3609 to 3750 1 to 142       142/145
(97 %)
8 diff
(94.5 %id)
BF770424 epid_tumor .b 3118 to 3327 20 to 226       207/247
(83 %)
18 diff
(92.8 %id)
BF837359 head_neck .c 3157 to 3508 352 to 1     Submitted on the opposite strand 352/352
(100 %)
4 diff
(98.9 %id)
BF989021 placenta_normal .j-u 1547 to 2066 532 to 13 E72G     520/537
(96 %)
0 diff
(100 %id)
BF989224 placenta_normal .j-u 1548 to 2066 15 to 531 Y55H N73D     517/546
(94 %)
5 diff
(99.1 %id)
BF993947 placenta_normal .c 1941 to 2335 13 to 408       396/408
(97 %)
6 diff
(98.6 %id)
BF995522 placenta_normal .j-u 1547 to 1917 13 to 383       371/383
(96 %)
6 diff
(98.5 %id)
BF995663 placenta_normal .j-u 1551 to 2066 1 to 516 F43L L56W     516/548
(94 %)
6 diff
(99.0 %id)
BF995664 placenta_normal .j-u 1547 to 2000 20 to 472 F43L D53G P89A     453/479
(94 %)
6 diff
(98.8 %id)
BF995673 placenta_normal .j-u 1547 to 1895 14 to 363       350/367
(95 %)
13 diff
(96.5 %id)
BF997855 placenta_normal .j-u 1540 to 2061 1 to 521 exact     521/521
(100 %)
5 diff
(99.1 %id)
BG012905 placenta_normal .c 3544 to 3804 265 to 7       259/265
(97 %)
0 diff
(100 %id)
BG013011 placenta_normal .c 3544 to 3810 268 to 1       268/268
(100 %)
2 diff
(99.3 %id)
BI016374 lung_tumor .f-u 521 to 821 1 to 299       299/299
(100 %)
5 diff
(98.4 %id)
BI060609 uterus_tumor .i 626 to 867 376 to 135       242/376
(64 %)
0 diff
(100 %id)
BQ342793 nervous_normal .j-u 1680 to 2082 414 to 13 exact     402/429
(93 %)
0 diff
(100 %id)
DA284086 corpus callosum .c 3661 to 4231 2 to 571   tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DC342340 thalamus .d 45 to 612 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BX093414 liver and spleen .j-u 2121 to 2829 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BX099664 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 3879 to 4377 1 to 499       499/499
(100 %)
0 diff
(100 %id)
F09306 brain, total brain .j-u 2980 to 3262 283 to 1       283/283
(100 %)
0 diff
(100 %id)
F11650 brain, total brain .j-u 1476 to 1735 1 to 260       260/260
(100 %)
0 diff
(100 %id)
F09624 brain, total brain .j-u 2988 to 3237 250 to 1       250/250
(100 %)
1 diff
(99.6 %id)
F11976 brain, total brain .j-u 1518 to 1806 1 to 289       289/289
(100 %)
0 diff
(100 %id)
CB151376 cervix, Uterine .j-u 1731 to 2267 1 to 536   tiling clone,   536/536
(100 %)
1 diff
(99.9 %id)
BU661577 blood .j-u 210 to 397 1 to 189       189/189
(100 %)
6 diff
(96.9 %id)
CN271733 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1601 to 2037 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
CN271734 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1189 to 1607 1 to 419       419/419
(100 %)
0 diff
(100 %id)
CN271735 embryonic stem cells, cell lines H1, H7, andH9 .c 714 to 1306 1 to 593       593/593
(100 %)
6 diff
(99.0 %id)
BP220889 colon .d 1 to 566 1 to 567   tiling clone,   567/567
(100 %)
7 diff
(98.8 %id)
BY998712   .j-u 4074 to 4169 1 to 98     Submitted on the opposite strand 98/98
(100 %)
4 diff
(96.0 %id)
DA459988 tongue, tumor tissue .j-u 1 to 557 7 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB314517 tongue, tumor tissue .j-u 2770 to 3262 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AL600959   .c 3769 to 4072 1 to 304       304/311
(97 %)
6 diff
(98.1 %id)
AL043992 testis .j-u 2649 to 3277 629 to 1       629/629
(100 %)
1 diff
(99.9 %id)
AL589386 human spinal cord .c 2685 to 3091 17 to 424       408/424
(96 %)
6 diff
(98.6 %id)
AL134602 brain .c 3707 to 4280 1 to 573   tiling clone,   573/573
(100 %)
2 diff
(99.7 %id)
AL704665 human skeletal muscle .c 2182 to 2778 1 to 601       601/601
(100 %)
9 diff
(98.6 %id)
AL704346 human skeletal muscle .c 2185 to 2834 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BX505228   .j-u 2616 to 3156 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AL039204 breast cancer .c 2781 to 3491 1 to 711       711/711
(100 %)
3 diff
(99.6 %id)
AL120878 melanoma (MeWo cell line) .c 705 to 1176 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
BX499680 Liver .c 947 to 1653 41 to 746       706/746
(94 %)
9 diff
(98.8 %id)
BX643895   .j-u 4178 to 4890 22 to 731   tiling clone,   710/731
(97 %)
6 diff
(99.2 %id)
BX643945   .c 1607 to 2042 1 to 436       436/436
(100 %)
12 diff
(97.3 %id)
DN918000   .j-u 3139 to 3752 615 to 1       615/615
(100 %)
4 diff
(99.4 %id)
DN918001   .j-u 2954 to 3591 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
DW463638 Liver .j-u 3110 to 3205 18 to 113       96/113
(84 %)
6 diff
(94.7 %id)
FN051321 breast carcinoma .j-u 2607 to 2712 106 to 1     Submitted on the opposite strand 106/106
(100 %)
0 diff
(100 %id)
FN071423 breast carcinoma .j-u 3048 to 3150 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
FN075314 breast carcinoma .j-u 2607 to 2712 104 to 1     Submitted on the opposite strand 104/104
(100 %)
4 diff
(96.2 %id)
FN094526 breast carcinoma .j-u 4228 to 4340 110 to 1     Submitted on the opposite strand 110/110
(100 %)
5 diff
(95.5 %id)
FN143088 breast carcinoma .b 3285 to 3347 64 to 2     Submitted on the opposite strand 63/65
(96 %)
0 diff
(100 %id)
FN150622 breast carcinoma .j-u 2859 to 2969 113 to 1     Submitted on the opposite strand 113/113
(100 %)
2 diff
(98.3 %id)
FN152433 breast carcinoma .j-u 3041 to 3176 1 to 134       134/134
(100 %)
6 diff
(95.6 %id)
FN155663 breast carcinoma .c 3695 to 3764 1 to 69       69/70
(98 %)
4 diff
(94.3 %id)
FN156773 breast carcinoma .j-u 2623 to 2713 1 to 89       89/103
(86 %)
3 diff
(97.1 %id)
FN160175 breast carcinoma .j-u 3165 to 3259 92 to 1     Submitted on the opposite strand 92/92
(100 %)
3 diff
(96.8 %id)
FN175888 breast carcinoma .j-u 1611 to 1735 122 to 1     Submitted on the opposite strand 122/122
(100 %)
3 diff
(97.6 %id)
GD138517   .c 2875 to 3074 1 to 200       200/204
(98 %)
5 diff
(97.6 %id)
BP234688 coronary artery .c 2599 to 3180 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BY797006 eye .j-u 2666 to 3190 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BY799337 eye .j-u 3778 to 4279 1 to 502       502/502
(100 %)
0 diff
(100 %id)
DA570984 whole embryo, mainly head .f-u 1 to 718 2 to 720   tiling clone, capped   719/722
(99 %)
5 diff
(99.4 %id)
DB357795 whole embryo, mainly head .f-u 1263 to 1795 537 to 1   tiling clone,   537/537
(100 %)
13 diff
(97.6 %id)
BP394048 pancreatic islet .b 2850 to 3348 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
T65525 whole brain .j-u 1476 to 1987 1 to 529 T28D K29*     529/529
(100 %)
20 diff
(96.3 %id)
R63241 placenta .j-u 3275 to 3519 247 to 1       247/247
(100 %)
2 diff
(99.2 %id)
R63295 placenta .j-u 2616 to 2932 13 to 331       319/331
(96 %)
6 diff
(98.2 %id)
H51720 liver and spleen .j-u 2121 to 2589 1 to 480       480/489
(98 %)
21 diff
(95.8 %id)
R83278 liver and spleen .j-u 2904 to 3256 372 to 9       364/377
(96 %)
0 diff
(100 %id)
R92393 liver and spleen .j-u 1814 to 2196 1 to 386       386/389
(99 %)
4 diff
(99.0 %id)
R92394 liver and spleen .j-u 2961 to 3251 295 to 1       295/295
(100 %)
6 diff
(98.0 %id)
H60518 liver and spleen .j-u 1561 to 1987 1 to 433 Y15C E72R N73E V74C S75X ...     433/433
(100 %)
7 diff
(98.4 %id)
H60519 liver and spleen .j-u 2908 to 3261 361 to 5       357/361
(98 %)
0 diff
(100 %id)
H69072 liver and spleen .j-u 1561 to 1953 1 to 400       400/413
(96 %)
10 diff
(97.6 %id)
H86068 eye, retina .j-u 2986 to 3247 265 to 1       265/269
(98 %)
3 diff
(98.9 %id)
H86404 eye, retina .j-u 1692 to 2087 1 to 404 K79X V80G F81L C82L D83*     404/405
(99 %)
12 diff
(97.1 %id)
H86093 eye, retina .j-u 2986 to 3247 264 to 1       264/266
(99 %)
2 diff
(99.3 %id)
H86433 eye, retina .j-u 1641 to 2017 1 to 381 K79E V80G F81L C82L D83*     381/390
(97 %)
6 diff
(98.5 %id)
H67463 liver and spleen .j-u 2965 to 3136 172 to 1       172/172
(100 %)
2 diff
(98.9 %id)
H78392 liver and spleen .b 2966 to 3355 404 to 11       394/405
(97 %)
6 diff
(98.6 %id)
H78490 liver and spleen .b 2307 to 2655 1 to 352       352/426
(82 %)
6 diff
(98.6 %id)
N30892.
matches multiple genes
placenta .a 150 to 645 517 to 1     also hits gene HERPUD1 517/517
(100 %)
27 diff
(94.8 %id)
N93819 lung .j-u 2831 to 3262 436 to 1       436/439
(99 %)
8 diff
(98.2 %id)
W44970 lung .j-u 2350 to 2787 1 to 440       440/440
(100 %)
7 diff
(98.5 %id)
AA001518 eye, retina .j-u 1645 to 2000 1 to 363 G67R G69W V70E G71L N73R ...     363/455
(79 %)
8 diff
(98.3 %id)
AA001546 eye, retina .j-u 2763 to 3261 501 to 1       501/502
(99 %)
2 diff
(99.7 %id)
AA019679 eye, retina .j-u 1585 to 1814 1 to 230       230/230
(100 %)
0 diff
(100 %id)
AA019806 eye, retina .j-u 3050 to 3261 212 to 1       212/212
(100 %)
0 diff
(100 %id)
AA704255 liver and spleen .b 2881 to 3352 473 to 1       473/473
(100 %)
3 diff
(99.4 %id)
AA099235 colon, tumor .b 863 to 1299 1 to 437       437/437
(100 %)
2 diff
(99.6 %id)
AA099665 colon, tumor .b 2897 to 3351 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AA410749 ovarian tumor, ovary .j-u 4055 to 4470 1 to 416       416/416
(100 %)
0 diff
(100 %id)
AA398030   .a 3139 to 3484 1 to 347   tiling clone,   347/347
(100 %)
2 diff
(99.5 %id)
AA420980   .j-u 2644 to 3049 1 to 406   fully sequenced,   406/406
(100 %)
1 diff
(99.8 %id)
AA469964   .j-u 3039 to 3265 227 to 1   fully sequenced,   227/227
(100 %)
0 diff
(100 %id)
AA479571 ovarian tumor, ovary .j-u 4056 to 4607 1 to 554   tiling clone,   554/554
(100 %)
1 diff
(99.9 %id)
AA489134 germinal center B cell .c 1262 to 1420 159 to 1     Submitted on the opposite strand 159/164
(96 %)
3 diff
(98.2 %id)
AA578396 Prostate, prostatic intraepithelial neoplasia - highgrade .c 2356 to 2556 1 to 201       201/209
(96 %)
2 diff
(99.1 %id)
AA581769 Kidney, kidney tumor .k 1 to 368 369 to 2 exact tiling clone, Submitted on the opposite strand 368/369
(99 %)
0 diff
(100 %id)
AA632461   .b 3067 to 3348 8 to 289   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 282/289
(97 %)
6 diff
(98.0 %id)
AA746749 alveolar rhabdomyosarcoma .j-u 2569 to 2730 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
AA745252 germinal center B cell .j-u 2771 to 3271 501 to 1       501/501
(100 %)
0 diff
(100 %id)
AA765098 germinal center B cell .j-u 2870 to 3271 402 to 1       402/402
(100 %)
1 diff
(99.8 %id)
AA829574 ovary .j-u 2931 to 3180 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
AA904018 carcinoid, lung .j-u 2828 to 3261 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AA865939 Kidney .j-u 2905 to 3262 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AA911689 pooled .j-u 2034 to 2116 83 to 1       83/83
(100 %)
1 diff
(98.8 %id)
AA916505 pooled .j-u 1806 to 2116 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
AI005643   .k 150 to 619 473 to 4   tiling clone,   470/473
(99 %)
0 diff
(100 %id)
AI022427 liver and spleen .b 2834 to 3352 519 to 1       519/519
(100 %)
8 diff
(98.5 %id)
AI183547   .j-u 1658 to 2116 460 to 1 exact     460/460
(100 %)
5 diff
(99.0 %id)
AI263200 pooled .c 637 to 1221 1 to 585     Submitted on the opposite strand 585/585
(100 %)
6 diff
(99.0 %id)
AI285999 pooled .c 631 to 1060 1 to 430     Submitted on the opposite strand 430/459
(93 %)
2 diff
(99.6 %id)
AI273546 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 4329 to 4714 404 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 387/387
(100 %)
3 diff
(99.3 %id)
AI335541 pooled germ cell tumors .c 3639 to 4070 1 to 432     Submitted on the opposite strand 432/432
(100 %)
4 diff
(99.1 %id)
AI338215 lung .j-u 2799 to 3265 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AI265801 borderline ovarian carcinoma, ovary .j-u 2911 to 3271 361 to 1       361/361
(100 %)
3 diff
(99.2 %id)
AI337452 colon, colon tumor, RER+ .c 325 to 555 231 to 1       231/231
(100 %)
0 diff
(100 %id)
AI436357 B-cell, chronic lymphotic leukemia .j-u 2778 to 3263 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AI497690 anaplastic oligodendroglioma, brain .b 2804 to 3350 546 to 1       546/546
(100 %)
3 diff
(99.5 %id)
AI687211 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j-u 2839 to 3270 431 to 1       431/431
(100 %)
2 diff
(99.6 %id)
AI660730 thymus, pooled .e 613 to 1194 582 to 1       582/582
(100 %)
5 diff
(99.2 %id)
AI741617 pooled .j-u 3008 to 3515 523 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 508/511
(99 %)
0 diff
(100 %id)
AI933392 anaplastic oligodendroglioma, brain .j-u 2840 to 3231 426 to 36   AAA   391/414
(94 %)
0 diff
(100 %id)
AI986030 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 2918 to 3354 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
BI494078 cochlea, ear .j-u 4598 to 4720 122 to 1   fully sequenced,   122/122
(100 %)
1 diff
(99.2 %id)
BI494079 cochlea, ear .j-u 4535 to 4721 1 to 187   fully sequenced,   187/187
(100 %)
5 diff
(97.4 %id)
AW085539 pooled .j-u 3254 to 3518 265 to 1       265/265
(100 %)
5 diff
(98.2 %id)
AW081604 colon, moderately differentiated adenocarcinoma .j-u 3671 to 4226 555 to 2       554/555
(99 %)
0 diff
(100 %id)
AW088916 ovary, tumor, 5 pooled (see description) .j-u 3035 to 3262 235 to 1       235/236
(99 %)
10 diff
(95.8 %id)
AW172284 pooled .c 666 to 1220 1 to 555     Submitted on the opposite strand 555/558
(99 %)
13 diff
(97.7 %id)
AW189337 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j-u 2810 to 3265 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AW207737   .c 638 to 1216 1 to 578     Submitted on the opposite strand 578/578
(100 %)
2 diff
(99.7 %id)
AW517353 cervix .c 666 to 955 1 to 290     Submitted on the opposite strand 290/313
(92 %)
25 diff
(92.1 %id)
AW516774 cervix, tumor .c 1137 to 1707 1 to 571     Submitted on the opposite strand 571/571
(100 %)
3 diff
(99.5 %id)
AW592396 pooled .h 1 to 575 576 to 2 P3Q P7R P8H T10S P14R ... tiling clone,   575/576
(99 %)
13 diff
(97.8 %id)
AW662082 2 pooled high-grade transitional celltumors, genitourinary tract .j-u 2671 to 3262 591 to 1       591/593
(99 %)
29 diff
(95.2 %id)
BF507568   .c 635 to 1168 1 to 534     Submitted on the opposite strand 534/534
(100 %)
2 diff
(99.7 %id)
BF510366   .b 2953 to 3365 413 to 1   tiling clone,   413/413
(100 %)
0 diff
(100 %id)
BF439109 pooled .b 2741 to 3354 613 to 1       613/613
(100 %)
12 diff
(98.1 %id)
BF002537 colon, colon tumor, RER+ .j-u 4296 to 4711 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
BF940502 fibrotheoma, ovary .c 655 to 1035 1 to 381     Submitted on the opposite strand 381/381
(100 %)
0 diff
(100 %id)
BF111417 pooled .j-u 3152 to 3518 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
BF593358 Kidney .j-u 4304 to 4714 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
BF207928 bladder, carcinoma, cell line .j-u 1641 to 2357 1 to 700 V19F L21S F22L G23D Y24T ...     700/867
(80 %)
31 diff
(96.5 %id)
BF529673 anaplastic oligodendroglioma with 1p/19qloss, brain .c 3689 to 4459 1 to 771   tiling clone,   771/951
(81 %)
45 diff
(95.3 %id)
BF676891 Prostate .c 3246 to 3930 1 to 684       684/685
(99 %)
14 diff
(98.0 %id)
BG151345 normal head/neck tissue .j-u 4479 to 4604 181 to 56     Submitted on the opposite strand 126/181
(69 %)
0 diff
(100 %id)
BF790447 muscle (skeletal) .j-u 1665 to 2292 1 to 622 F43L V44Y C45A T46L L48F ...     622/840
(74 %)
15 diff
(98.3 %id)
BG390306 embryonal carcinoma, cell line, testis .j-u 2506 to 3262 1 to 762   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 762/762
(100 %)
15 diff
(98.1 %id)
BG471299 eye, retinoblastoma .b 2746 to 3371 1 to 627       627/773
(81 %)
13 diff
(98.4 %id)
BG536850 lung .j-u 2539 to 3270 1 to 733   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 733/734
(99 %)
24 diff
(96.8 %id)
BG568889 Liver .j-u 1872 to 2686 1 to 816       816/820
(99 %)
13 diff
(98.5 %id)
BG570480 lung .j-u 2342 to 3114 1 to 768       768/769
(99 %)
17 diff
(97.8 %id)
BG745250 Spleen .g 1 to 723 1 to 737 C18G R27K G28E Y29G V31* tiling clone,   737/739
(99 %)
24 diff
(96.8 %id)
BG914369 anaplastic oligodendroglioma with 1p/19qloss, brain .c 3710 to 4424 40 to 754   tiling clone,   715/754
(94 %)
6 diff
(99.3 %id)
BI559626 testis .c 1949 to 2644 1 to 696       696/696
(100 %)
5 diff
(99.3 %id)
BI559528 testis .c 572 to 1301 1 to 700       591/700
(84 %)
37 diff
(94.8 %id)
BM876326 insulinoma, Pancreas .j-u 2703 to 3277 584 to 1       584/584
(100 %)
56 diff
(90.5 %id)
BQ014152 Chondrosarcoma, Left Pubic Bone .b 2614 to 3366 752 to 1       752/752
(100 %)
3 diff
(99.7 %id)
BQ004400 Chondrosarcoma, Left Pelvis .j-u 2575 to 3262 699 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 683/683
(100 %)
6 diff
(99.2 %id)
BM987522 mixed .j-u 4271 to 4708 460 to 22   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 439/442
(99 %)
0 diff
(100 %id)
CB217122 normal endometrium, mid-secretory phase,cycle day 23, uterus .j-u 2379 to 3015 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BQ421037 embryonal carcinoma, cell line, testis .j-u 3540 to 4394 1 to 865   tiling clone,   865/869
(99 %)
15 diff
(98.3 %id)
BQ224369 melanotic melanoma, skin .j-u 2530 to 3285 12 to 776       765/964
(79 %)
28 diff
(97.1 %id)
BQ086167 Islets of Langerhans, Pancreas .j-u 1816 to 2396 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ102277 Islets of Langerhans, Pancreas .j-u 2689 to 3262 574 to 1       574/574
(100 %)
1 diff
(99.9 %id)
CK822889 Islets of Langerhans, Pancreas .j-u 2702 to 3262 561 to 1       561/561
(100 %)
1 diff
(99.9 %id)
CK822890 Islets of Langerhans, Pancreas .j-u 1816 to 2359 1 to 544       544/544
(100 %)
0 diff
(100 %id)
CA841668 Pancreas, Purified pancreatic islet .j-u 3758 to 4202 446 to 1   fully sequenced,   446/446
(100 %)
1 diff
(99.8 %id)
CA841964 Pancreas, Purified pancreatic islet .j-u 3266 to 3788 6 to 528   tiling clone, fully sequenced,   523/528
(99 %)
6 diff
(98.9 %id)
BU570917 testis .j-u 1667 to 2511 1 to 862 Y15C     862/933
(92 %)
26 diff
(97.3 %id)
CB988415 Human Placenta, placenta .e 1 to 759 28 to 789   tiling clone,   762/789
(96 %)
10 diff
(98.8 %id)
CD638627 pooled .j-u 3028 to 3518 1 to 491   tiling clone,   491/492
(99 %)
2 diff
(99.6 %id)
CD639092 pooled .j-u 2836 to 3518 1 to 680       680/686
(99 %)
7 diff
(99.0 %id)
TI_44347884   .c 1947 to 2644 121 to 818       698/818
(85 %)
7 diff
(99.2 %id)
TI_44348181   .c 577 to 1301 86 to 780       586/780
(75 %)
18 diff
(97.7 %id)
N56130   .j-u 1597 to 1766 1 to 170       170/170
(100 %)
0 diff
(100 %id)
CB140747 Liver .j-u 1774 to 2232 1 to 459       459/459
(100 %)
0 diff
(100 %id)
CB161882 Liver .f-u 628 to 1108 1 to 481   tiling clone,   481/481
(100 %)
0 diff
(100 %id)
BP431808   .j-u 2920 to 3262 376 to 34   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
BP432362   .j-u 2978 to 3262 318 to 34   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 285/285
(100 %)
0 diff
(100 %id)
BP293367 lung .c 3570 to 4142 8 to 584       577/584
(98 %)
6 diff
(99.0 %id)
BP293633 lung .c 3564 to 4134 1 to 574   tiling clone,   574/582
(98 %)
5 diff
(99.2 %id)
NM_000333.3   .c 9 to 7231 1 to 7223 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 7223/7223
(100 %)
0 diff
(100 %id)
NM_001128149.2   .d 1 to 6403 1 to 6403 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 6403/6403
(100 %)
0 diff
(100 %id)
NM_001177387.1   .a 542 to 7388 1 to 6847 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 6847/6847
(100 %)
0 diff
(100 %id)
DA762939 tongue .c 2170 to 2749 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA792608 brain .j-u 1 to 546 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BP314402 mammary gland .c 2169 to 2750 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA824163 pericardium .c 3644 to 4211 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA829802 placenta .j-u 1399 to 1916 2 to 521   tiling clone, capped   520/525
(99 %)
5 diff
(99.1 %id)
DB374729 placenta .j-u 2905 to 3262 360 to 1       360/377
(95 %)
7 diff
(98.2 %id)
BP332319 renal proximal tubule .c 1847 to 2425 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CR985994 T-Lymphocytes .e 444 to 1194 1 to 751   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 751/751
(100 %)
4 diff
(99.5 %id)
DC388662 small intestine .d 35 to 609 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
DA968658 stomach .j-u 1404 to 1958 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB334559 stomach .j-u 2712 to 3262 551 to 1       551/551
(100 %)
1 diff
(99.9 %id)
BM193879 leukopheresis .j-u 2308 to 2823 516 to 1       516/516
(100 %)
4 diff
(99.3 %id)
BM150428 leukopheresis .c 3094 to 3473 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
BM151587 leukopheresis .j-u 2314 to 2823 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
BM151557 leukopheresis .c 3094 to 3295 1 to 202       202/218
(92 %)
11 diff
(95.0 %id)
BM193387 leukopheresis .j-u 2521 to 2823 305 to 1       305/307
(99 %)
3 diff
(99.1 %id)
DC405394 thymus .d 64 to 637 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DB128936 thymus .c 967 to 1510 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB138645 thymus .i 1 to 536 2 to 538 L17X K18E A19S P20S L21T ... capped   537/537
(100 %)
2 diff
(99.7 %id)
DB138864 thymus .c 2281 to 2823 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB141507 thymus .c 2093 to 2629 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
TI_149283107   .j-u 2266 to 3036 848 to 83   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 766/815
(93 %)
25 diff
(97.0 %id)
TI_149295409   .j-u 273 to 1074 903 to 107       797/904
(88 %)
0 diff
(100 %id)
TI_154025827   .j-u 2568 to 3262 775 to 81   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 695/695
(100 %)
0 diff
(100 %id)
DC415825 trachea .d 78 to 639 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DB234743 trachea .c 2203 to 2789 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BQ012223 placenta .j-u 3667 to 4203 555 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/537
(100 %)
1 diff
(99.9 %id)
BM983995 lung, Primary Lung Epithelial Cells .j-u 2410 to 3036 645 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 627/628
(99 %)
2 diff
(99.7 %id)
BU683615 lung, Primary Lung Cystic Fibrosis EpithelialCells .j-u 482 to 1074 630 to 38   tiling clone, AAA   593/612
(96 %)
0 diff
(100 %id)
BM728307 eye, fetal eye .j-u 1577 to 2093 1 to 516 exact   Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 516/516
(100 %)
2 diff
(99.7 %id)
BU742846 eye, fetal eye .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
CA433000 mixed .j-u 2652 to 3262 626 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 610/610
(100 %)
1 diff
(99.9 %id)
CA440076 lung, Metastatic Chondrosarcoma .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
BQ364517 stomach .j-u 1816 to 2359 1 to 544     Suspected internal deletion, this clone was ignored 544/544
(100 %)
0 diff
(100 %id)
CN267586 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j-u 3758 to 4202 446 to 1     This clone was ignored 446/446
(100 %)
1 diff
(99.8 %id)
AV653283 corresponding non cancerous liver tissue .j-u 3758 to 4202 446 to 1     Submitted on the opposite strand, submitted on the opposite strand 446/446
(100 %)
1 diff
(99.8 %id)
DA990323 synovial membrane tissue from rheumatioidarthritis .j-u 3266 to 3788 6 to 528   tiling clone, capped Suspected internal deletion, this clone was ignored 523/528
(99 %)
6 diff
(98.9 %id)
DB334973 synovial membrane tissue from rheumatioidarthritis .j-u 3266 to 3788 6 to 528   tiling clone, Suspected internal deletion, this clone was ignored 523/528
(99 %)
6 diff
(98.9 %id)
DB163319 thymus .j-u 1667 to 2511 1 to 862   capped This clone was ignored 862/933
(92 %)
26 diff
(97.3 %id)
DB347004 thymus .e 1 to 759 28 to 789   tiling clone, This clone was ignored 762/789
(96 %)
10 diff
(98.8 %id)
CB988415 Human Placenta, placenta .e 1 to 759 28 to 789   tiling clone,   762/789
(96 %)
10 diff
(98.8 %id)
CD638627 pooled .j-u 3028 to 3518 1 to 491   tiling clone,   491/492
(99 %)
2 diff
(99.6 %id)
CD639092 pooled .j-u 2836 to 3518 1 to 680       680/686
(99 %)
7 diff
(99.0 %id)
TI_44347884   .c 1947 to 2644 121 to 818       698/818
(85 %)
7 diff
(99.2 %id)
TI_44348181   .c 577 to 1301 86 to 780       586/780
(75 %)
18 diff
(97.7 %id)
N56130   .j-u 1597 to 1766 1 to 170       170/170
(100 %)
0 diff
(100 %id)
CB140747 Liver .j-u 1774 to 2232 1 to 459       459/459
(100 %)
0 diff
(100 %id)
CB161882 Liver .f-u 628 to 1108 1 to 481   tiling clone,   481/481
(100 %)
0 diff
(100 %id)
BP431808   .j-u 2920 to 3262 376 to 34   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
BP432362   .j-u 2978 to 3262 318 to 34   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 285/285
(100 %)
0 diff
(100 %id)
BP293367 lung .c 3570 to 4142 8 to 584       577/584
(98 %)
6 diff
(99.0 %id)
BP293633 lung .c 3564 to 4134 1 to 574   tiling clone,   574/582
(98 %)
5 diff
(99.2 %id)
NM_000333.3   .c 9 to 7231 1 to 7223 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 7223/7223
(100 %)
0 diff
(100 %id)
NM_001128149.2   .d 1 to 6403 1 to 6403 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 6403/6403
(100 %)
0 diff
(100 %id)
NM_001177387.1   .a 542 to 7388 1 to 6847 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 6847/6847
(100 %)
0 diff
(100 %id)
DA762939 tongue .c 2170 to 2749 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA792608 brain .j-u 1 to 546 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BP314402 mammary gland .c 2169 to 2750 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA824163 pericardium .c 3644 to 4211 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA829802 placenta .j-u 1399 to 1916 2 to 521   tiling clone, capped   520/525
(99 %)
5 diff
(99.1 %id)
DB374729 placenta .j-u 2905 to 3262 360 to 1       360/377
(95 %)
7 diff
(98.2 %id)
BP332319 renal proximal tubule .c 1847 to 2425 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CR985994 T-Lymphocytes .e 444 to 1194 1 to 751   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 751/751
(100 %)
4 diff
(99.5 %id)
DC388662 small intestine .d 35 to 609 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
DA968658 stomach .j-u 1404 to 1958 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB334559 stomach .j-u 2712 to 3262 551 to 1       551/551
(100 %)
1 diff
(99.9 %id)
BM193879 leukopheresis .j-u 2308 to 2823 516 to 1       516/516
(100 %)
4 diff
(99.3 %id)
BM150428 leukopheresis .c 3094 to 3473 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
BM151587 leukopheresis .j-u 2314 to 2823 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
BM151557 leukopheresis .c 3094 to 3295 1 to 202       202/218
(92 %)
11 diff
(95.0 %id)
BM193387 leukopheresis .j-u 2521 to 2823 305 to 1       305/307
(99 %)
3 diff
(99.1 %id)
DC405394 thymus .d 64 to 637 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DB128936 thymus .c 967 to 1510 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB138645 thymus .i 1 to 536 2 to 538 L17X K18E A19S P20S L21T ... capped   537/537
(100 %)
2 diff
(99.7 %id)
DB138864 thymus .c 2281 to 2823 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB141507 thymus .c 2093 to 2629 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
TI_149283107   .j-u 2266 to 3036 848 to 83   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 766/815
(93 %)
25 diff
(97.0 %id)
TI_149295409   .j-u 273 to 1074 903 to 107       797/904
(88 %)
0 diff
(100 %id)
TI_154025827   .j-u 2568 to 3262 775 to 81   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 695/695
(100 %)
0 diff
(100 %id)
DC415825 trachea .d 78 to 639 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DB234743 trachea .c 2203 to 2789 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BQ012223 placenta .j-u 3667 to 4203 555 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/537
(100 %)
1 diff
(99.9 %id)
BM983995 lung, Primary Lung Epithelial Cells .j-u 2410 to 3036 645 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 627/628
(99 %)
2 diff
(99.7 %id)
BM983995 lung, Primary Lung Epithelial Cells .j-u 2410 to 3036 645 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 627/628
(99 %)
2 diff
(99.7 %id)
BU683615 lung, Primary Lung Cystic Fibrosis EpithelialCells .j-u 482 to 1074 630 to 38   tiling clone, AAA   593/612
(96 %)
0 diff
(100 %id)
BU683615 lung, Primary Lung Cystic Fibrosis EpithelialCells .j-u 482 to 1074 630 to 38   tiling clone, AAA   593/612
(96 %)
0 diff
(100 %id)
BM728307 eye, fetal eye .j-u 1577 to 2093 1 to 516 exact   Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 516/516
(100 %)
2 diff
(99.7 %id)
BM728307 eye, fetal eye .j-u 1577 to 2093 1 to 516 exact   Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 516/516
(100 %)
2 diff
(99.7 %id)
BU742846 eye, fetal eye .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
BU742846 eye, fetal eye .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
CA433000 mixed .j-u 2652 to 3262 626 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 610/610
(100 %)
1 diff
(99.9 %id)
CA440076 lung, Metastatic Chondrosarcoma .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
CA440076 lung, Metastatic Chondrosarcoma .j-u 2620 to 3262 659 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j-u, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI